NAALAD2
protein-codingN-acetylated alpha-linked acidic dipeptidase 2, the group of M28 metallopeptidases
Gene summary
This gene is a member of the N-acetylated alpha-linked acidic dipeptidase (NAALADase) gene family. The representative member of this family is the gene encoding human prostate-specific membrane antigen (PSM), which is a marker of prostatic carcinomas and is the first to be shown to possess NAALADase activity. NAALADase cleaves N-acetyl-L-aspartate-L-glutamate (NAAG), which is a neuropeptide expressed both in the central nervous systems and in the periphery and is thought to function as a neurotransmitter. The product of this gene is a type II integral membrane protein. Transient transfection of this gene confers both NAALADase and dipetidyl peptidase IV activities to mammalian cells. This gene is highly expressed in ovary and testis as well as within discrete brain areas. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~61.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NAALAD2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005467.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 97 | 4 | 101 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 98 | 6 | 0 | 104 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005458.1 | 19 | MANE Select | |
| Ensembl | ENSP00000432481.1 | 19 | MANE Select | |
| RefSeq | NP_001287859.1 | 18 | Standard | |
| Ensembl | ENSP00000320083.4 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of amino acids and derivatives
- Metabolism
- Amino acid synthesis and interconversion (transamination)
Biological Process
- proteolysis
- cellular amino acid biosynthetic process
- neurotransmitter catabolic process
Molecular Function
- carboxypeptidase activity
- serine-type peptidase activity
- metallopeptidase activity
- dipeptidyl-peptidase activity
- dipeptidase activity
Cellular Component
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000534061
- Coding exons
- 19
- Length
- 61380
- Individuals with no LoFs
- 125542
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 204
- Defined
- 125748
- p
- 0.000819
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.474 | 359 | 385 | 0.932 | 0.0000186 | 4828 |
| Missense (PolyPhen) | 145 | 163.52 | 0.88677 | 2027 | ||
| Synonymous | 0.334 | 126 | 131 | 0.963 | 0.00000603 | 1387 |
| Loss of Function | 1.07 | 35 | 42.6 | 0.822 | 0.00000208 | 546 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.0010 | notable |
| Latino/Admixed American | 0.0011 | 0.0011 | notable |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.0021 | 0.0019 | notable |
| Finnish | 0.00046 | 0.00046 | rare |
| European (Non-Finnish) | 0.00063 | 0.00060 | rare |
| South Asian | 0.0011 | 0.0010 | notable |
| Other | 0.0013 | 0.0013 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Has N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Also exhibits a dipeptidyl-peptidase IV type activity. Inactivate the peptide neurotransmitter N- acetylaspartylglutamate. {ECO:0000269|PubMed:10085079}.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.969
- RVIS EVS
- 0.07
- RVIS percentile EVS
- 59.04
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.136
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |